Synbiotic’s 13% Surge: Market Manipulation or Hidden Crash? Uncover the TruthSynbiotic’s 13% price jump is a thin‑liquidity, pump‑and‑dump warning, not a growth signal.SYNBIOTIC SEGermany Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated Vanessa Liu 22/10/2026, 07:30 3 minutes to read
Synbiotic’s 24‑Hour Collapse: Why Investors Must Re‑examine Their PositionSynbiotic’s share plunged 23.8% in 24 hrs, now at €0.15, revealing deep liquidity and valuation woes in Germany’s cannabis sector.SYNBIOTIC SEGermany Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated Vanessa Liu 21/10/2026, 07:57 4 minutes to read
SynBiotic SE Files for Insolvency, Shares Plunge to €0.17 – Market ImpactSynBiotic SE files for insolvency, slashing share price to €0.17 on Xetra – discover how this medical‑cannabis firm’s fate and future valuation could impact investors.SYNBIOTIC SEGermany Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated Elliot Mercer 20/10/2026, 17:30 2 minutes to read